ProMedica Flower Hospital is 311-bed non-profit hospital in Sylvania, Ohio operated by ProMedica as a division of ProMedica Toledo Hospital. The hospital is home to the Hickman Cancer Center, an emergency department, primary stroke center, and adult impatient psychiatry services.

There are 311 beds in ProMedica Flower Hospital.

During the past decade, ProMedica Flower Hospital conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 114 clinical trials were completed, i.e. on average, 115.2% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 69 clinical trials were completed. i.e. 255.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ProMedica Flower Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 104 trials, followed by "SWOG Cancer Research Network" with 31 trials sponsored, "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "NRG Oncology" with 17 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ProMedica Flower Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 99 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "ProMedica Flower Hospital" are "Recurrent Breast Carcinoma" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Breast Cancer" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "ProMedica Flower Hospital" in a lesser frequency.

Most popular intervention types in "ProMedica Flower Hospital" are "Drug" (178 trials), "Other" (129 trials), "Biological" (86 trials), "Radiation" (48 trials) and "Procedure" (40 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (79 trials), "Quality-of-Life Assessment" (51 trials), "Carboplatin" (24 trials), "Paclitaxel" (24 trials) and "Questionnaire Administration" (24 trials). Other intervention names were less common.

The vast majority of trials in "ProMedica Flower Hospital" are 156 trials for "All" genders, 39 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are NaN active trials in "ProMedica Flower Hospital". undefined are not yet recruiting, 29 are recruiting, 101 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 57 completed trials in ProMedica Flower Hospital, 4 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in ProMedica Flower Hospital, 4 "Phase 1" clinical trials were conducted, 105 "Phase 2" clinical trials and 123 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".